How to talk about mental health at work in Japan
Japan has long held a cultural ideal of 'enduring hardship' (我慢, gaman), especially in the workplace. This often means pushing through stress, exhaustion or emotional pain rather than speaking up. While mental health is still widely considered a private matter in Japan, that doesn't mean you have to struggle alone.
If you're feeling overwhelmed, anxious or depressed, support is available. And while Japan's workplace culture is still catching up, awareness around mental health is growing. Here's how to speak up, stay culturally aware, and protect your well-being in the process.
Cultural Barriers (But Change Is Starting)
Know the Signs Before It's Too Late
How to Talk About It (Japanese Work Culture Version)
Know Your Rights (Even if They're Hard to Use)
You Can Speak With the Company Doctor
A Disability Certificate May Help
If Work Isn't Safe, Get Outside Help
Therapy & Counseling (English-Speaking)
Legal & Employment Advice
You're Not Overreacting—You're Protecting Yourself
Cultural Barriers (But Change Is Starting)
Opening up about depression, anxiety or burnout in Japan can feel like admitting failure — a taboo in a collectivist culture where group harmony often outweighs individual needs. Though attitudes are shifting, mental illness has long been viewed through a lens of spiritual imbalance or personal weakness.
A 2022 survey by the Japan Productivity Center found only 15.3% of workers had received mental health support at work, despite nearly 60% reporting high levels of stress. Government reforms are encouraging better work-life balance, and some companies now offer occupational health services or counseling. Still, access remains uneven, and many employees hesitate to seek help.
By 2024, nearly half of full-time workers in Japan reported 'quiet quitting' — doing only the minimum required —underscoring just how widespread burnout has become.
Know the Signs Before It's Too Late
Don't let work take priority over your mental health.
Common Signs of Burnout
Crying quietly between meetings or after work
Chronic headaches, nausea, or other unexplained physical symptoms
Difficulty falling asleep, or waking up already tired
Trouble focusing, forgetfulness, or missing deadlines
A sense of emotional numbness or disconnection from your work
Social isolation can make this worse. Some people experience panic attacks on crowded morning trains—a symptom so common it's often overlooked.
Speaking up early, taking a break or seeking outside help is not a weakness. It's a form of self-leadership—and it might be the smartest move you make in your career.
How to Talk About It (Japanese Work Culture Version)
Talking about mental health at work is never easy, and in Japan, it often requires a careful balance of honesty, discretion and cultural sensitivity. The workplace tends to prize harmony, hierarchy and emotional restraint.
Start with Physical Language First
In many Japanese workplaces, it's more acceptable to frame emotional or mental distress as a physical issue. This isn't dishonest — it's a culturally appropriate way to open the door to support.
Phrases that work well include:
I'm not feeling well (体調が悪いです, taicho ga warui desu)
I'm going to the clinic regularly (通院しています, tsuin shiteimasu)
I need a short period of rest (少し休養が必要です, sukoshi kyuyo ga hitsuyō desu)
If You Mention Mental Health, Keep It Neutral
Should you choose to be more specific, avoid emotionally charged language unless you're speaking to someone trained in mental health or someone you trust deeply.
Try:
I'm receiving treatment for mental health reasons (メンタルヘルスのことで通院しています, mentaru herusu no koto de tsuin shiteimasu)
I'm receiving support from a professional (専門家のサポートを受けています, senmonka no sapoto o uketeimasu)
I'm experiencing some stress (少しストレスが溜まっています, sukoshi sutoresu ga tamatteimasu)
Know Your Rights (Even if They're Hard to Use)
Click here to read more.
External Link
https://gaijinpot.com/
© GaijinPot
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
a day ago
Japan Startup Conducts Trial on Heart Treatment Using iPS Cells
News from Japan Society Jul 29, 2025 16:23 (JST) Tokyo, July 29 (Jiji Press)--A Japanese startup has said it conducted a clinical trial to transplant a treatment sheet containing cardiac muscle cells derived from human induced pluripotent stem, or iPS, cells into a patient with a heart muscle disease. The surgery to transplant the sheet into the patient with dilated cardiomyopathy was performed at the end of May at the Tokyo Women's Medical University Hospital. The patient has already been discharged from the hospital. The regenerative medicine startup, iHeart Japan Corp., based in the western city of Kyoto, said on Monday that the patient will undergo monitoring so that the company can assess the treatment's safety and efficacy. IHeart Japan layered three types of cells, including those of heart muscles and blood vessels. Gelatin particles were added to the layers of the cells to create the round sheet measuring about 4 centimeters in diameter and 1 millimeter in thickness. When placed on the surface of the heart, the sheet is expected to improve the heart's contraction partly through the functions of exosomes, or vesicles produced by cells. [Copyright The Jiji Press, Ltd.] Jiji Press
Japan Today
2 days ago
- Japan Today
Walking 7,000 steps a day a huge boost to health: research
Step up: Walking even just a little more every day could have big health benefits People who walk 7,000 steps a day have a dramatically lower risk of a broad range of serious health problems, the largest review of the evidence yet said. The most widely promoted target for people tracking their number of steps is 10,000 -- but that figure reportedly originally came from a 1960s marketing campaign for a Japanese pedometer. To find a more scientific target, an international team of researchers sifted through 57 previous studies that covered 160,000 people. The results published in the Lancet Public Health journal found that walking 7,000 steps a day nearly halved people's risk of early death from all causes, compared to 2,000 steps. The study also looked into health problems not previously covered by research into step counts. Walking 7,000 steps a day was linked to people's risk of dementia falling by 38 percent, depression dropping 22 percent and diabetes decreasing 14 percent. It was also associated with lower rates of cancer and falls, though the researchers warned this was based on less evidence. "You don't need to hit 10,000 steps a day to get major health benefits," Paddy Dempsey, a study co-author and medical researcher at Cambridge University, told AFP. "The biggest gains happen before 7,000 steps, and then benefits tend to level off," he said. While people's speeds vary widely, 7,000 steps adds up to roughly an hour of walking throughout the day. Dempsey emphasised that people already managing 10,000 or more steps should keep it up. But he had a message for people who might find 7,000 steps daunting: "don't be discouraged". "If you're only getting 2,000–3,000 steps a day, aim to add an extra 1,000 steps. That's just 10–15 minutes of light walking spread across the day," he said. Andrew Scott, a researcher at the University of Portsmouth not involved in the study, said that "it demonstrates that overall more is always better". "People should not focus too much on the numbers, particularly on days where activity is limited," he added. The World Health Organization recommends at least 150 minutes of moderate to intense physical activity a week. Nearly a third of people worldwide do not reach this target, according to the WHO. © 2025 AFP
Nikkei Asia
2 days ago
- Nikkei Asia
Japan's Nikon, others to invest $675m in cutting-edge drug production
Nikon and other companies produce advanced therapies, some using stem cells, on a contract basis. (Photo obtained by Nikkei) KOHEI YAMADA and TATSUYA OZAKI TOKYO -- Japanese companies such as Nikon and materials maker AGC plan to invest a total of over 100 billion yen ($675 million) by fiscal 2027 to boost production of stem cell-based and other cutting-edge drugs, an area where Japan trails the U.S. and Europe. Regenerative medicines -- a field that includes products used to re-create lost tissue, gene therapies and CAR T-cell cancer therapies -- are expected to see strong growth.
